Literature DB >> 15608691

TRAIL and immunity: more than a license to kill tumor cells.

N Corazza, G Brumatti, C Schaer, I Cima, C Wasem, T Brunner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15608691     DOI： 10.1038/sj.cdd.4401542

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  4 in total

1.  Genetic engineering of platelets to neutralize circulating tumor cells.

Authors:  Jiahe Li; Charles C Sharkey; Brittany Wun; Jane L Liesveld; Michael R King
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

2.  TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.

Authors:  Nadia Corazza; Sabine Jakob; Corinne Schaer; Steffen Frese; Adrian Keogh; Deborah Stroka; Daniela Kassahn; Ralph Torgler; Christoph Mueller; Pascal Schneider; Thomas Brunner
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

3.  A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.

Authors:  Horng-Ren Yang; Ching-Chuan Hsieh; Lianfu Wang; John J Fung; Lina Lu; Shiguang Qian
Journal:  Microsurgery       Date:  2010-05       Impact factor: 2.425

4.  Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail gene-deficient mice.

Authors:  Yi-Chen Lin; John H Richburg
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.